ABBVIE INC. DL-,01 - stock earnings
4AB.DE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 1.3 billion EUR | 11.4 billion EUR |
| 2023Q4 | 743.6 million EUR | 12.9 billion EUR |
| 2023Q3 | 1.7 billion EUR | 13.2 billion EUR |
| 2023Q2 | 1.9 billion EUR | 12.8 billion EUR |
| 2023Q1 | 219.3 million EUR | 11.2 billion EUR |
| 2022Q4 | 2.3 billion EUR | 14.1 billion EUR |
| 2022Q3 | 4.0 billion EUR | 15.1 billion EUR |
| 2022Q2 | 883.6 million EUR | 13.9 billion EUR |
| 2022Q1 | 4.0 billion EUR | 12.1 billion EUR |
| 2021Q4 | 3.6 billion EUR | 13.1 billion EUR |
| 2021Q3 | 2.7 billion EUR | 12.4 billion EUR |
| 2021Q2 | 646.0 million EUR | 11.8 billion EUR |
| 2021Q1 | 3.0 billion EUR | 11.1 billion EUR |
| 2020Q4 | 29.6 million EUR | 11.4 billion EUR |
| 2020Q3 | 2.0 billion EUR | 11.0 billion EUR |
| 2020Q2 | -656.9 million EUR | 9.3 billion EUR |
| 2020Q1 | 2.7 billion EUR | 7.8 billion EUR |
| 2019Q4 | 2.5 billion EUR | 7.8 billion EUR |
| 2019Q3 | 1.7 billion EUR | 7.7 billion EUR |
| 2019Q2 | 651.5 million EUR | 7.3 billion EUR |
| 2019Q1 | 2.2 billion EUR | 7.0 billion EUR |
| 2018Q4 | -1.6 billion EUR | 7.3 billion EUR |
| 2018Q3 | 2.4 billion EUR | 7.1 billion EUR |
| 2018Q2 | 1.7 billion EUR | 7.2 billion EUR |
| 2018Q1 | 2.3 billion EUR | 6.4 billion EUR |
| 2017Q4 | 43.5 million EUR | 6.5 billion EUR |
| 2017Q3 | 1.4 billion EUR | 5.9 billion EUR |
| 2017Q2 | 1.7 billion EUR | 6.1 billion EUR |
| 2017Q1 | 1.6 billion EUR | 6.1 billion EUR |
| 2016Q4 | 1.3 billion EUR | 6.5 billion EUR |
| 2016Q3 | 1.4 billion EUR | 5.7 billion EUR |
| 2016Q2 | 1.4 billion EUR | 5.8 billion EUR |
| 2016Q1 | 1.2 billion EUR | 5.3 billion EUR |
| 2015Q4 | 1.4 billion EUR | 5.9 billion EUR |
| 2015Q3 | 1.1 billion EUR | 5.3 billion EUR |
| 2015Q2 | 1.2 billion EUR | 4.9 billion EUR |
| 2015Q1 | 943.7 million EUR | 4.7 billion EUR |
| 2014Q4 | -666.0 million EUR | 4.5 billion EUR |
| 2014Q3 | 398.7 million EUR | 4.0 billion EUR |
| 2014Q2 | 804.7 million EUR | 3.6 billion EUR |
| 2014Q1 | 712.6 million EUR | 3.3 billion EUR |
| 2013Q4 | 816.8 million EUR | 3.7 billion EUR |
| 2013Q3 | 714.3 million EUR | 3.5 billion EUR |
| 2013Q2 | 819.3 million EUR | 3.6 billion EUR |
| 2013Q1 | 755.3 million EUR | 3.4 billion EUR |
| 2012Q4 | 1.2 billion EUR | 3.9 billion EUR |
| 2012Q3 | 1.2 billion EUR | 3.5 billion EUR |
| 2012Q2 | 1.0 billion EUR | 3.6 billion EUR |
| 2012Q1 | 663.4 million EUR | 3.1 billion EUR |
| 2011Q4 | 893.5 million EUR | 3.8 billion EUR |
| 2011Q3 | 9.1 million EUR | 3.2 billion EUR |
| 2011Q2 | 1.1 billion EUR | 3.0 billion EUR |
| 2011Q1 | 512.1 million EUR | 2.8 billion EUR |
4AB.DE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.4 billion EUR | 49.1 billion EUR |
| 2022 | 11.0 billion EUR | 54.1 billion EUR |
| 2021 | 10.1 billion EUR | 49.4 billion EUR |
| 2020 | 3.8 billion EUR | 37.6 billion EUR |
| 2019 | 7.0 billion EUR | 29.7 billion EUR |
| 2018 | 5.0 billion EUR | 28.6 billion EUR |
| 2017 | 4.4 billion EUR | 23.6 billion EUR |
| 2016 | 5.7 billion EUR | 24.4 billion EUR |
| 2015 | 4.7 billion EUR | 20.9 billion EUR |
| 2014 | 1.5 billion EUR | 16.4 billion EUR |
| 2013 | 3.0 billion EUR | 13.6 billion EUR |
| 2012 | 4.0 billion EUR | 13.9 billion EUR |
| 2011 | 2.6 billion EUR | 13.5 billion EUR |
| 2010 | 3.1 billion EUR | 11.8 billion EUR |
| 2009 | 3.2 billion EUR | 9.9 billion EUR |
4AB.DE
Price: €150.14
Dividend Yield: 3.86%
Forward Dividend Yield: 3.82%
Payout Ratio: 225.88%
Dividend Per Share: 5.76 EUR
Earnings Per Share: 2.55 EUR
P/E Ratio: 65.10
Exchange: GER
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2151
Market Capitalization: 264.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 9
DGR3: 1.29%
DGR5: 2.27%